Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina

This publication has 22 references indexed in Scilit:

• Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome)
  Published by Oxford University Press (OUP) ,1999
• Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial
  The Lancet, 1999
• Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin Inhibitor
  Circulation, 1998
• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
  New England Journal of Medicine, 1997
• Reactivation of Unstable Angina after the Discontinuation of Heparin
  New England Journal of Medicine, 1992
• von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.
  Journal of Clinical Investigation, 1991
• Biochemical and Pharmacologic Inequivalence of Low Molecular Weight Heparins
  Annals of the New York Academy of Sciences, 1989
• Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro
  Thrombosis Research, 1986
• Effect of Heparin and Heparin Fractions on Platelet Aggregation
  Journal of Clinical Investigation, 1980
• The Platelet Aggregating Effect of Eight Commercial Heparins
  Scandinavian Journal of Haematology, 1972